# Capadenoson in Angina Pectoris

> **NCT00518921** · PHASE2 · WITHDRAWN · sponsor: **Bayer**

## Conditions studied

- Chronic Stable Angina

## Interventions

- **DRUG:** Capadenoson (BAY 68-4986)
- **DRUG:** Capadenoson (BAY 68-4986)
- **DRUG:** Capadenoson (BAY 68-4986)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00518921
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-03
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2011-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518921, "Capadenoson in Angina Pectoris". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00518921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*